Coronary artery disease and peripheral artery disease are both global health issues that affect millions of lives each year across the world. It’s known that they affect over 7 million and 8 million people above the age of 65 years respectively, so it’s clear that it is one of the most serious problems that medical science is currently dealing with. It’s thought that this problem is only likely to increase in the future.
Now, according to a new report from the research and consulting firm GlobalData, bioabsorbable stents are likely to become the next step in treatment once the medical world has provided enough clinical data and prices have been lowered.
Stent technology has developed rapidly over the last few years to address the challenges of treating arterial diseases. This new report looks at bioabsorbable stents, which offer temporary scaffolding to the vessel and then disappear after they have done their job, leaving behind a healed artery. Bioabsorbable stents are not very far into their development and there is a long road ahead before widespread adoption into clinical practice is reached. But the report from GlobalData suggests that the technology holds the potential to revolutionise the treatment of arterial disease patients.
Even though traditional stents improve patient prognosis in comparison to invasive cardiac surgeries, complications such as restenosis and thrombosis are still a major concern. It’s worth noting that there is also demand from physicians to reduce the need for dual anti-platelet therapy, required when implanting bare metal and drug-eluting stents. Fully degradable and absorbable stents are able to tackle all these concerns, and could potentially ensure quality long-term results for the patient.
Comments are closed.